RESUMO

OBJECTIVE: To determine the factors associated with prolonged hospital-stay after appendectomy in SARS-CoV-2 pandemic. MATERIAL AND METHODS: A retrospective observational cohort study included 420 patients after surgery for acute appendicitis between March 2019 and March 2020, April 2020 and April 2021. There were 336 patients before the SARS-COV-2 pandemic, and 84 ones underwent surgery during the pandemic. RESULTS: Incidence of prolonged hospital stay was 15% and 26%, respectively (RR 1.76). RR is more than 1 and assumes SARS-CoV-2 infection as a risk factor. CONCLUSION: There is an association between SARS-CoV-2 infection and prolonged hospital-stay after surgery for acute appendicitis (RR 1.76).

Assuntos

RESUMO

ABSTRACT Objectives: The aim of this study was to evaluate whether criteria exist to guide election between the use the three- or four-arm technique in robotic partial nephrectomy (RPN) instead of just the surgeon's preference. Material and Methods: We performed a retrospective review of 80 patients submitted to RPN from May 2016 to February 2020. The patients were divided into two groups of 40, the first submitted to the surgical procedure with use of three robotic arms and the second with four arms. The group division was performed independently of the complexity of the cases, age or gender of the patients and laterality of the renal lesions. Peri- and postoperative data were analyzed for comparison between the two groups. Results: Both techniques had similar oncological outcomes (positive tumor margins), renal function preservation (warm ischemia time) and hemorrhagic complications (estimated blood loss and renal artery pseudoaneurysm), with a small difference in the need for blood transfusion, favoring the technique with three arms. Conclusions: The two robotic partial nephrectomy techniques had similar oncological and postoperative outcomes, with minimal perioperative complications. The three-arm technique is safe and feasible regardless of the complexity and size of the tumor. Additionally, the use of the three-arm technique reduced surgery costs by US$ 413.00 per patient.

RESUMO

OBJECTIVES: The aim of this study was to evaluate whether criteria exist to guide election between the use the three- or four-arm technique in robotic partial nephrectomy (RPN) instead of just the surgeon's preference. MATERIAL AND METHODS: We performed a retrospective review of 80 patients submitted to RPN from May 2016 to February 2020. The patients were divided into two groups of 40, the first submitted to the surgical procedure with use of three robotic arms and the second with four arms. The group division was performed independently of the complexity of the cases, age or gender of the patients and laterality of the renal lesions. Peri- and postoperative data were analyzed for comparison between the two groups. RESULTS: Both techniques had similar oncological outcomes (positive tumor margins), renal function preservation (warm ischemia time) and hemorrhagic complications (estimated blood loss and renal artery pseudoaneurysm), with a small difference in the need for blood transfusion, favoring the technique with three arms. CONCLUSIONS: The two robotic partial nephrectomy techniques had similar oncological and postoperative outcomes, with minimal perioperative complications. The three-arm technique is safe and feasible regardless of the complexity and size of the tumor. Additionally, the use of the three-arm technique reduced surgery costs by US$ 413.00 per patient.

Assuntos

RESUMO

ABSTRACT Introduction: Nephrometric scores play an interesting role in nephron sparring surgery (NSS) planning. The aim of this study is to evaluate if R.E.N.A.L. score (RS) is capable to predict the occurrence of adverse events in laparoscopic NSS. Materials and Methods: We prospectively studied 150 laparoscopic NSS between 2015 and 2018 to evaluate the relationship between RS and incidence of adverse events. Clavien 3 or superior complications, warm ischemia time (WIT) over 30 minutes, tumor violation, positive surgical margins (PSM) and necessity of amplification of renal parenchyma during the resection of the masses to obtain free margins were considered as adverse events. We compared each item of the RS isolated and divided the patients between low risk and high risk. Results: Adverse results occurred in 48 cases (32%). Amplification of the margin of resection was observed in 28 cases (19%). WIT exceeded 30 minutes in 9 cases (6.1%), complications Clavien 3 or superior occurred in 13 cases (9%) and PSM were detected en 6 cases (4%). Comparing the patients with adverse outcomes and each item of the RS we did not find any statistical difference, but when divided into high risk and low risk, we found that patients in the high risk group had a higher tendency to present ad-verse results - 25.84% vs. 44.26% (p=0.03). Conclusions: RS system is a good way to predict adverse outcomes in NSS, especially in cases over 7. Further studies should focus on robotic approach and patient's characteristics other than the masses' aspects.

Assuntos

RESUMO

INTRODUCTION: Nephrometric scores play an interesting role in nephron sparring surgery (NSS) planning. The aim of this study is to evaluate if R.E.N.A.L. score (RS) is capable to predict the occurrence of adverse events in laparoscopic NSS. MATERIALS AND METHODS: We prospectively studied 150 laparoscopic NSS between 2015 and 2018 to evaluate the relationship between RS and incidence of adverse events. Clavien 3 or superior complications, warm ischemia time (WIT) over 30 minutes, tumor violation, positive surgical margins (PSM) and necessity of amplification of renal parenchyma during the resection of the masses to obtain free margins were considered as adverse events. We compared each item of the RS isolated and divided the patients between low risk and high risk. RESULTS: Adverse results occurred in 48 cases (32%). Amplification of the margin of resection was observed in 28 cases (19%). WIT exceeded 30 minutes in 9 cases (6.1%), complications Clavien 3 or superior occurred in 13 cases (9%) and PSM were detected en 6 cases (4%). Comparing the patients with adverse outcomes and each item of the RS we did not find any statistical difference, but when divided into high risk and low risk, we found that patients in the high risk group had a higher tendency to present ad-verse results - 25.84% vs. 44.26% (p=0.03). CONCLUSIONS: RS system is a good way to predict adverse outcomes in NSS, especially in cases over 7. Further studies should focus on robotic approach and patient's characteristics other than the masses' aspects.

Assuntos

RESUMO

High-performance sulfonated polysulfone (SPSf) mixed-matrix membranes (MMMs) were fabricated via a nonsolvent-induced phase separation (NIPS) method using zeolitic imidazolate frameworks-67 (ZIF-67) as a crosslinker. Acid-base crosslinking occurred between the sulfonic acid groups of SPSf and the tertiary amine groups of the embedded ZIF-67, which improved the dispersion of ZIF-67 and simultaneously improved the membrane strzcture and permselectivity. The dispersion of ZIF-67 in the MMMs and the acid-base crosslinking reaction were verified by energy-dispersive X-ray spectroscopy (EDX), X-ray diffractometry (XRD), Fourier-transform infrared spectroscopy (FTIR), and X-ray photoelectron spectroscopy (XPS). The pore structure analysis of MMMs indicated that filling ZIF-67 into SPSf enhanced the average surface pore sizes, surface porosities and more micropore in cross-sections. The crossflow filtrations showed the MMMs have higher pure water fluxes (57 to 111 L m-2 h-1) than the SPSf membrane (55 L m-2 h-1) but also higher bovine serum albumin (BSA) rejection rate of 93.9-95.8%, a model protein foulant. The MMMs showed a higher water contact angle than the SPSf membrane due to the addition of hydrophobic ZIF-67 and acid-base crosslinking, and also maintained high thermal stability evidenced by the thermogravimetric analysis (TGA) results. At the optimal ZIF-67 concentration of 0.3 wt%, the water flux of the SPSf-Z67-0.3 membrane was 82 L m-2 h-1 with a high BSA rejection rate of 95.3% at 0.1 MPa and better antifouling performance (FRR = 70%).

Assuntos

RESUMO

OBJECTIVE: To analyze the demographic and epidemiological profile of children and adolescents victims of sexual violence treated in a Unit of Forensic Medicine and the relationship between victims and perpetrators. METHODS: A descriptive study, with data collection from information gathered from sex abuse reports performed in 2009 on victims of sexual violence aged less than 18 years. The data collection tool was a form filled out with demographic information about the victim - gender and age - and information regarding the sexual violence -, location of the occurrence, time elapsed between abuse and expert report, complaints reported, sexological examination findings, description of lesions outside the genital region, and aggressor's relationship to victim. RESULTS: In 2009, 421 individuals victim of sexual violence were assisted. Of those, 379 (90%) were younger than 18 years, and 66 cases were excluded from these reports. Most were female (81.2%). The most affected age group was 10 to 13 years old (36.7%), followed by 5 to 9 year-olds (30.7%). In most cases (86.3%), there were family or friendship ties between victims and perpetrators, being most frequently accused an acquaintance or friend of the family (42.3%), followed by the stepfather (16.6%) and the father (10.9%). CONCLUSION: The results are similar to other studies conducted in the country. This work aims at filling a gap caused by the lack of research on this topic in the State, hoping to collaborate to improve public policies against child sexual abuse.

Assuntos

RESUMO

BACKGROUND AND OBJECTIVES: Blood pressure monitoring offers a limited understanding of the hemodynamic consequences of spinal anesthesia for cesarean delivery. The purpose of this study was to assess, with the aid of a non-invasive cardiac output monitor based on bioreactance, the hemodynamic changes during elective cesarean delivery under spinal anesthesia in which intermittent boluses of phenylephrine were used to prevent and treat hypotension. METHODS: This observational study was conducted with the Research Ethics Board approval, and all participants provided written informed consent. Healthy patients undergoing elective cesarean delivery under spinal anesthesia were enrolled. Intermittent boluses of phenylephrine were administered in an attempt to maintain systolic blood pressure at baseline levels, and patients were assessed with a non-invasive cardiac output monitor based on bioreactance. Hemodynamic data was collected continuously at baseline, and during the postspinal and postdelivery periods. Data was analyzed using a mixed model ANOVA, and a p < 0.05 was considered significant. RESULTS: Systolic blood pressure was maintained within 79.2 ± 14.2 and 105.8 ± 10.0 percent of baseline during the postspinal period, and 78.4 ± 11.3 and 100.9 ± 10.7 percent of baseline in the postdelivery period (mean ± SD) There were significant fluctuations in systolic blood pressure, heart rate, and cardiac output during the postspinal period, and significant fluctuations in systolic blood pressure and cardiac output in the postdelivery period. CONCLUSIONS: A new non-invasive monitor based on bioreactance reveals significant hemodynamic fluctuations during cesarean delivery under spinal anesthesia, despite attempts to maintain blood pressure at baseline levels with intermittent boluses of phenylephrine.

Assuntos

RESUMO

BACKGROUND AND OBJECTIVES: The effect of BMI on the spread of intrathecal bupivacaine is controversial. This study assessed the ED95 of intrathecal bupivacaine for elective cesarean delivery in obese and normal weight women. METHODS: We studied normal weight (BMI < 25 kg x m(-2)) and obese (BMI > 30 kg x m(-2)) women with singleton term pregnancies undergoing elective cesarean delivery. The study was conducted as a single blinded, up-down sequential allocation study (modified by the Narayana rule). All patients received a combined spinal-epidural anesthesia with a variable intrathecal dose of hyperbaric 0.75% bupivacaine, plus fentanyl 10 microg and morphine 100 microg. The first patient received 9 mg of bupivacaine. Supplemental anesthesia was provided through the epidural catheter if required. The primary outcome was successful analgesia, defined as a sensory block to at least T6, and no request for supplemental anesthesia. The ED95 for the satisfactory outcome was determined by a logistic model with non-log-transformed doses. RESULTS: Twenty-four normal weight and sixteen obese patients were enrolled. The estimated ED95 for all forty patients was 12.92 mg (95% CI: 11.49 to 34.77). The estimated ED95 for the normal weight and the obese subgroups were similar at 12.78 mg (95% CI: 10.75 to + infinity) and 11.86 mg (95%CI: 11.31 to 15.61), respectively. CONCLUSIONS: If single shot spinal anesthesia is used for cesarean delivery, obese and normal weight patients should receive similar doses of hyperbaric bupivacaine. Although in our study the effective dose 95% could not be precisely determined, it is possible to state that it is at least 11.49 mg.

Assuntos

RESUMO

Justificativa e objetivos: Os efeitos do IMC na dispersão subaracnóidea de bupivacaína são controversos. O presente estudo avaliou a ED95 de bupivacaína subaracnóidea em cesarianas eletivas em mulheres obesas...

Background and objectives: The effect of BMI on the spread of intrathecal bupivacaine is controversial. This study assessed the ED95 of intrathecal bupivacaine for elective cesarean delivery in obese...

Justificativa y objetivos: Los efectos del IMC en la dispersión intratecal de bupivacaína son controvertidos. El presente estudio evaluó la ED95 de bupivacaína intratecal en cesáreas de elección en mujeres obesas...

Assuntos

RESUMO

BACKGROUND AND OBJECTIVES: Although regional anesthesia is widely used for pain control in obstetrics, it may not be appropriate for patients with thrombocytopenia due to the risk of neuraxial hematoma. There is no strong evidence to suggest the minimum platelet count that is necessary to ensure the safe practice of regional anesthesia. The purpose of this study was to review the safety of regional anesthesia in non-preeclamptic thrombocytopenic parturients at our institution over a 5-year period. METHODS: A retrospective chart review was performed in all the non-preeclamptic obstetric patients who delivered at our facility between April 2001 and March 2006, and had platelet counts < 100 x 10(9).L(-1) on the day of anesthesia. The etiology of the thrombocytopenia, type of anesthesia, mode of delivery and major anesthetic complications were noted. RESULTS: Seventy-five patients were identified, 47 of whom (62.6%) had received regional anesthesia. The etiology of their thrombocytopenia was immune thrombocytopenic purpura in 49 patients, gestational thrombocytopenia in 20 and other causes in 6 patients. Regional anesthesia was administered in 91.9% of the patients with platelet counts of 80 to 99 x 10(9).L(-1) and in 48.1% of the patients with platelet counts of 50 to 79 x 10(9).L(-1). None of the 11 patients with platelet counts below 50 x 10(9).L(-1) received regional anesthesia. There were no neurological complications. CONCLUSIONS: In our series, regional anesthesia was safely administered in pregnant patients with platelet counts between 50-79 x 10(9).L(-1). Our results are in keeping with other series in the literature. We suggest that in non-preeclamptic patients with stable platelet counts and no history or clinical signs of bleeding, the lower limit of platelet count for regional anesthesia should be 50 x 10(9).L(-1).

Assuntos

RESUMO

JUSTIFICATIVA E OBJETIVOS: Apesar de a anestesia regional ser amplamente utilizada no controle da dor em obstetrícia, seu uso pode não ser apropriado nas pacientes com trombocitopenia por causa do risco de hematoma no neuroeixo. Não existem fortes evidências sugerindo número mínimo de plaquetas necessário para garantir a segurança na realização da anestesia regional. O objetivo deste estudo foi rever a segurança da anestesia regional em pacientes com trombocitopenia não pré-eclâmptica na instituição durante período de cinco anos. MÉTODO: Foi realizada revisão retrospectiva dos prontuários médicos de todas as pacientes obstétricas não pré-eclâmpticas cujo parto foi realizado na instituição entre abril de 2001 e março de 2006 e que apresentaram contagem de plaquetas < 100 x 109.L-1 no dia da anestesia. A etiologia da trombocitopenia, o tipo de anestesia, tipo de parto e as principais complicações anestésicas foram registrados. RESULTADOS: Foram identificadas 75 pacientes, das quais 47 (62,2%) receberam anestesia regional. A etiologia da trombocitopenia incluiu púrpura trombocitopênica imune, em 49 pacientes; trombocitopenia gestacional, em 20 pacientes; e outras causas em seis pacientes. Anestesia regional foi utilizada em 91,9% das pacientes com nível de plaquetas entre 80 a 99 x 109.L-1 e em 48,1% das pacientes com nível de plaquetas entre 50 e 79 x 109.L-1. Em nenhuma das 11 pacientes que apresentavam plaquetas abaixo de 50 x 109.L-1 foi administrada anestesia regional. Não houve complicações neurológicas. CONCLUSÕES: Nos casos estudados, a anestesia regional foi administrada com segurança nas gestantes com nível de plaquetas entre 50 - 79 x 109.L-1. Neste estudo os resultados são semelhantes aos de outras séries relatadas na literatura. Sugere-se que nas pacientes sem eclâmpsia com um nível estável de plaquetas e sem história prévia ou sinais clínicos de sangramento, o limite inferior de 50 x 109.L-1 deve ser adotado.

BACKGROUND AND OBJECTIVES: Although regional anesthesia is widely used for pain control in obstetrics, it may not be appropriate for patients with thrombocytopenia due to the risk of neuraxial hematoma. There is no strong evidence to suggest the minimum platelet count that is necessary to ensure the safe practice of regional anesthesia. The purpose of this study was to review the safety of regional anesthesia in non-preeclamptic thrombocytopenic parturients at our institution over a 5-year period. METHODS: A retrospective chart review was performed in all the non-preeclamptic obstetric patients who delivered at our facility between April 2001 and March 2006, and had platelet counts < 100 × 109.L-1 on the day of anesthesia. The etiology of the thrombocytopenia, type of anesthesia, mode of delivery and major anesthetic complications were noted. RESULTS: Seventy-five patients were identified, 47 of whom (62.6%) had received regional anesthesia. The etiology of their thrombocytopenia was immune thrombocytopenic purpura in 49 patients, gestational thrombocytopenia in 20 and other causes in 6 patients. Regional anesthesia was administered in 91.9% of the patients with platelet counts of 80 to 99 × 109.L-1 and in 48.1% of the patients with platelet counts of 50 to 79 × 109.L-1. None of the 11 patients with platelet counts below 50 × 109.L-1 received regional anesthesia. There were no neurological complications. CONCLUSIONS: In our series, regional anesthesia was safely administered in pregnant patients with platelet counts between 50-79 × 109.L-1. Our results are in keeping with other series in the literature. We suggest that in non-preeclamptic patients with stable platelet counts and no history or clinical signs of bleeding, the lower limit of platelet count for regional anesthesia should be 50 × 109.L-1.

JUSTIFICATIVA Y OBJETIVOS: A pesar de que la anestesia regional esté siendo muy utilizada en el control del dolor en obstetricia, su uso puede no ser muy apropiado en las pacientes con trombocitopenia, debido al riesgo de hematoma en el neuro eje. No existen fuertes evidencias que sugieran un número mínimo de plaquetas necesario para garantizar la seguridad en la realización de la anestesia regional. El objetivo de este estudio fue analizar la seguridad de la anestesia regional en pacientes con trombocitopenia no preeclámptica en la institución durante un período de cinco años. MÉTODO: Fue realizada revisión retrospectiva de las historias clínicas médicas de todas las pacientes obstétricas no preeclámpticas cuyo parto fue realizado en la institución entre abril de 2001 y marzo de 2006 y que presentaron < 100 x 109.L-1 de plaquetas el día de la anestesia. La etiología de la trombocitopenia, el tipo de anestesia, tipo de parto y las principales complicaciones anestésicas fueron registrados. RESULTADOS: Se identificaron 75 pacientes, de las cuales 47 (62,2%) recibieron anestesia regional. La etiología de la trombocitopenia incluyó púrpura trombocitopénica inmune en 49 pacientes, trombocitopenia de gestación en 20 pacientes, y otras causas en seis pacientes. La anestesia regional fue utilizada en un 91.9% de las pacientes con nivel de plaquetas entre 80 a 99 x 109.L-1 y en 48.1% de las pacientes con nivel de plaquetas entre 50 y 79 x 109.L-1. Ninguna de las 11 pacientes que presentaban plaquetas por debajo de 50 x 109.L-1 recibió anestesia regional. No hubo complicaciones neurológicas. CONCLUSIONES: En los casos estudiados, la anestesia regional fue administrada con seguridad en las gestantes con nivel de plaquetas entre...

Assuntos

RESUMO

A osteopetrose é uma osteopatia hereditária caracterizada pela deficiência na reabsorção óssea que ocorre por disfunção dos osteoclastos. Com o acúmulo de material osteóide que oblitera o canal medular, ocorre hematopoiese extramedular (hepato-esplenomegalia), obliteração dos forames dos nervos cranianos (cegueira, surdez, paralisias faciais), macrocefalia, protusão da fronte, hipertelorismo, exoftalmo, aumento da pressão intracraniana, retardo na erupção dentária, atraso no crescimento, atraso no desenvolvimento neuropsicomotor, e a morte ocorre precocemente nos primeiros anos de vida. A única alternativa terapêutica curativa é o transplante de medula óssea (TMO) de doador HLA idêntico, pois restabelece a hematopoiese e a função monócito-macrófago, com melhora das lesões ósseas e anormalidades hematopoiéticas, embora não reverta as alterações sensoriais já instaladas. Os autores relatam casos de duas crianças portadoras de osteopetrose maligna submetidas ao transplante de medula óssea com sucesso. A primeira encontra-se no dia +1260 do TMO, com melhora evidente da radiologia esquelética, sem progressão das deficiências neurológicas que apresentava, e com biópsia óssea sem sinais de osteopetrose. O segundo paciente encontra-se no dia + 700, com sinais de reabsorção óssea e sem progressão dos danos neurológicos. Os autores chamam a atenção para a necessidade de diagnóstico precoce da osteopetrose e o rápido encaminhamento para o transplante de medula óssea antes da instalação de seqüelas neurológicas definitivas.

Osteopetrosis is an inherited disorder characterized by the inability to reabsorb and remodel bone due to osteoclast dysfunction. The encroachment by bone and mineralized cartilage of the medullary cavities leads to extramedullary hematopoiesis (hepatosplenomegaly) and cranial-nerve foramina leads to blindness, auditory nerve damage, and occulomotor and facial nerve palsies. Defective bone re-absorption also leads to macrocephaly, frontal bossing, hypertelorism, exophthalmos, increased intracranial pressure, retarded tooth eruption, retarded linear growth and psychomotor delay. Death occurs within the first years of life. The only curative therapy is allogeneic bone marrow transplantation with a HLA-identical donor, which restores hematopoiesis, monocyte-macrophage function and bone recovery, but there is no sensorial deficit restoration once present. The authors report two cases of allogeneic bone marrow transplant for infantile malignant osteopetrosis. The first child, on day 1260 after bone marrow transplantation (BMT), showed radiologic bone recovery and no progression of neurological deficits with a bone biopsy showing no signs of osteopetrosis. The second child showed signs of bone re-absorption and no progression of neurological deficits on day 700. The authors emphasize the importance of early diagnosis of osteopetrosis and the necessity of bone marrow transplantation before neurological deficits have begun.

Assuntos

RESUMO

A principal causa da gengivite é o acúmulo de placa bacteriana que pode ser evitada com a utilização de meios preventivos mecânicos e químicos. A clorexidina é um agente químico de amplo espectro antibacteriano. O objetivo do estudo foi a avaliação dos efeitos clínicos da clorexidina na saúde gengival, por meio de sua ação antibacteriana no controle da gengivite, em pacientes que apresentam pouca higienização da cavidade bucal no Distrito de São Carlos - Porto Velho – RO. Através do Projeto NAPRA (Núcleo de Apoio a População Ribeirinhada Amazônia) foram selecionados 15 voluntários com gengivite, que foram divididos em grupo controle (cinco voluntários) e grupo clorexidina (10 voluntários). Para o grupo clorexidina foi administrado fármaco a base de clorexidina (Periogard® Colgate) e ao grupo controle foi administrado placebo (água). Os grupos foram monitorados a cada cinco dias, através de exames físicos e Índice Gengival de Lõe, durante um período de 15 dias. Antes do início do estudo, tanto o grupo estudo como o grupo controle encontravam-se equilibrados estatisticamente quanto à média de Índice Gengival de Lõe. Foi observado que o uso de clorexidina por um periodo de 10 dias reduziu e controlou significantemente a gengivite em pacientes que apresentavam higiene bucal deficiente, através de sua ação antibacteriana.

Assuntos

RESUMO

Introduçäo: A Doença de Parkinson (DP) é um dos distúrbios do movimento mais encontrados na populaçäo idosa. Cursa com perda progressiva e irreversível de células da substância negra (locus niger) do mesencéfalo, o que resultará numa diminuiçäo da produçäo de dopamina, levando à sintomatologia da DP. Objetivo: Averiguar a relevância de testes eletrofisiológicos, capazes de monitorar a integridade funcional das vias cerebrais, no diagnóstico e/ou prognóstico de pacientes com DP, uma vez que tais testes näo-invasivos säo de fácil aplicabilidade, rápidos e facilmente compreendidos por quem participa de sua aplicaçäo. Forma de estudo: Prospectivo clínico randomizado. Material e Método: Grupo de 32 pacientes com diagnóstico prévio de DP, submetidos aos testes de potencial evocado BERA e P300. Pacientes de ambos os sexos, entre 44 e 85 anos, com tempo de doença variando de 8 meses a 21 anos de evoluçäo. Resultados: os valores do BERA e do P300 encontrados em pacientes com DP näo se mostraram diferentes dos limites de normalidade para a idade. Conclusäo: Observou-se integridade das vias auditivas em pacientes portadores de DP. Uma vez que a latência do P300 aumenta de forma linear com a idade, a partir dos 45 anos, aceitando-se um aumento de 1 a 1,5ms por ano¹; observou-se integridade nas vias cerebrais que refletem a habilidade de performance cognitiva em pacientes portadores de DP sem comprometimento demencial exuberante